Ionela Iacobas1, Denise M Adams2, Sheena Pimpalwar3, Thuy Phung1, Francine Blei4, Patricia Burrows5, Juan Carlos Lopez-Gutierrez6, Michael A Levine7, Cameron C Trenor2. 1. TCH Vascular Anomalies Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas. 2. Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. 3. UT Southwestern Medical Center, Dallas, Texas. 4. Vascular Anomalies Program, Lenox Hill Hospital, New York, New York. 5. Radiology Department, Medical College of Wisconsin, Milwaukee, Wisconsin. 6. Pediatric Surgery Department, Hospital Universitario Quirónsalud, Madrid, Madrid, Spain. 7. Center for Bone Health, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Abstract
OBJECTIVE: Complicated lymphatic anomalies (CLAs) are chronic, progressive, and debilitating conditions that share clinical features, yet key elements for optimal evaluation and management have not been established. We aimed to formulate expert opinion consensus-based guidelines for comprehensive evaluation of CLAs. STUDY DESIGN: Patient support groups dedicated to CLAs organized an international conference for vascular anomaly experts from 16 specialties to address the objective. Participants received a set of questions before the meeting and reviewed the literature. Data extracted from international lymphatic anomaly registries were presented and the group separated for panel discussions during the conference. The recommendations achieving consensus within the panel were presented to the entire audience. Open debate occurred until majority approval was achieved. RESULTS: The expert group was composed of 52 physicians who defined the clinical elements required to evaluate and diagnose a CLA. The radiology panel established the preferred anatomical and functional imaging methods for diagnosis and the elements required to be described during interpretation. Two medical panels compiled the metabolic and hematologic tests at diagnosis and also recommended functional studies. The surgical group recommended precautions for biopsy and the pathology panel provided biopsy specimen processing guidelines. CONCLUSIONS: Patients with CLAs require a comprehensive and targeted diagnostic plan for appropriate management, prevention of complications, and conservation of resources. As this population is managed by diverse medical and surgical specialties, we offer an expert multidisciplinary consensus-based opinion on the current literature and on data extracted from international lymphatic anomaly registries.
OBJECTIVE: Complicated lymphatic anomalies (CLAs) are chronic, progressive, and debilitating conditions that share clinical features, yet key elements for optimal evaluation and management have not been established. We aimed to formulate expert opinion consensus-based guidelines for comprehensive evaluation of CLAs. STUDY DESIGN:Patient support groups dedicated to CLAs organized an international conference for vascular anomaly experts from 16 specialties to address the objective. Participants received a set of questions before the meeting and reviewed the literature. Data extracted from international lymphatic anomaly registries were presented and the group separated for panel discussions during the conference. The recommendations achieving consensus within the panel were presented to the entire audience. Open debate occurred until majority approval was achieved. RESULTS: The expert group was composed of 52 physicians who defined the clinical elements required to evaluate and diagnose a CLA. The radiology panel established the preferred anatomical and functional imaging methods for diagnosis and the elements required to be described during interpretation. Two medical panels compiled the metabolic and hematologic tests at diagnosis and also recommended functional studies. The surgical group recommended precautions for biopsy and the pathology panel provided biopsy specimen processing guidelines. CONCLUSIONS:Patients with CLAs require a comprehensive and targeted diagnostic plan for appropriate management, prevention of complications, and conservation of resources. As this population is managed by diverse medical and surgical specialties, we offer an expert multidisciplinary consensus-based opinion on the current literature and on data extracted from international lymphatic anomaly registries.
Authors: Ernesto Solorzano; Andrew L Alejo; Hope C Ball; Joseph Magoline; Yusuf Khalil; Michael Kelly; Fayez F Safadi Journal: Int J Mol Sci Date: 2022-07-26 Impact factor: 6.208
Authors: Katarzyna Wojciechowska-Durczynska; Arkadiusz Zygmunt; Marta Mikulak; Marta Ludwisiak; Andrzej Lewinski Journal: Int J Environ Res Public Health Date: 2022-09-16 Impact factor: 4.614
Authors: Catherine E de Keyser; Michael S Saltzherr; Eelke M Bos; M Carola Zillikens Journal: Front Endocrinol (Lausanne) Date: 2020-02-05 Impact factor: 5.555